Kairos Pharma issues investor presentation; CEO to present at H.C. Wainwright conference

Kairos Pharma, LTD.

Chief Executive Officer John Yu to present at H.C. Wainwright 28th Annual Global Investment Conference in New York, Sept 14-16, 2026.
Presentation provides update on clinical program and activities; published on company website.
No financial, clinical, or guidance figures disclosed in the 8-K filing text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.